Optimizing SABR delivery for synchronous multiple lung tumors using volumetric-modulated arc therapy

Abstract

Severe toxicity was uncommon following SABR using VMAT for up to three lung tumors. Further investigations of planning parameters are needed in patients presenting with more lesions.